Related Experiment Video
Updated: Jan 17, 2026
09:39
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
10.0K
Treatable Neuropathies.
Satish Khadilkar1, Jharna Mahajan2, Hiral Halani3
1Dean, Professor, and Head, Department of Neurology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India, Corresponding Author.
The Journal of the Association of Physicians of India
|September 16, 2025
Summary
Peripheral neuropathy, a common neurological issue, has many causes and symptoms. This review focuses on identifying and treating various neuropathies early to reduce patient disability.
Area of Science:
- Neurology
- Internal Medicine
Background:
- Peripheral neuropathy is a frequent neurological condition with diverse causes and presentations.
- Effective management hinges on accurate diagnosis and timely intervention.
Purpose of the Study:
- To review the spectrum of treatable peripheral neuropathies.
- To detail their etiologies, diagnostic criteria, and therapeutic advancements.
Main Methods:
- Literature review focusing on metabolic, immune, infectious, toxic, and nutritional neuropathies.
- Analysis of clinical pattern recognition and neuropathy characterization for diagnosis.
Main Results:
- The range of treatable neuropathies is expanding.
- Early diagnosis and treatment significantly decrease morbidity and disability.
Conclusions:
- Prompt identification of treatable neuropathies is crucial for better patient outcomes.
- This review provides a comprehensive overview of common and uncommon treatable neuropathies.
Related Concept Videos
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.4K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.4K
01:26Peripheral Artery Disease IV: Nursing Management
351
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
351
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364
01:15Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
01:24Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K